2
results
FILTER BY Subject:
- Biology/Life Sciences [1] http://purl.org/dc/terms/subject http://instance.metastore.ingenta.com/content/subjects/biology-life-sciences
- Pharmacology [1] http://purl.org/dc/terms/subject http://instance.metastore.ingenta.com/content/subjects/pharmacology
FILTER BY Publisher:
- Bentham Science Publishers [2] http://purl.org/dc/terms/isPartOf http://instance.metastore.ingenta.com/content/bentham
-
-
Pharmaceutical Nanotechnology
Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.
-
-
-
Protein and Peptide Letters
Protein & Peptide Letters publishes letters, original research papers, mini-reviews, and guest-edited issues in all important aspects of protein, peptide, and proteomics research, including structural studies, advances in recombinant expression, function, synthesis, enzymology, immunology, molecular modeling, drug design and large-scale proteomic analyses. Manuscripts must have significant elements of novelty, timeliness, and urgency that merit rapid publication. Reports of crystallization and preliminary structure determination of biologically important proteins are considered only if they include significant new approaches or deal with proteins of immediate importance, and preliminary structure determinations of biologically important proteins. Purely theoretical/review papers should provide new insight into the principles of protein/peptide structure and function. Manuscripts describing computational work should include some experimental data to provide confirmation of the results of calculations.
Protein & Peptide Letters focuses on the following key areas of protein, peptide and proteomics research:- Advances in Recombinant Expression
- Biotechnology
- Conformational Analysis
- Chemical Synthesis
- Drug Design
- Enzymology
- Function
- Immunology
- Molecular Recognition
- Pharmacology
- Protein Engineering
- Protein Folding
- Purification and Analysis
- Sequencing
- Structure Studies
- Proteomics and Systems Biology
- Post-Translational Modifications
- Protein-Protein Interactions
- Quantitative and Structural Proteomics
- Mass Spectrometry and Bioinformatics in Proteomics
- Post-Translational Modification (PTM) Proteomics
- Computational Proteomics
- Clinical Proteomics
- Pharmacoproteomics
- Metaproteomics
-